EK
Insider selling
Eric Karas sold $250K of SPRY stock
Eric Karas, Chief Commercial Officer of ARS Pharmaceuticals, Inc. (SPRY), sold 25,000 shares of SPRY stock worth $250K, per an SEC Form 4 filed Jun 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 12, 2026, 1 day before it was made public.
SPRY has moved -62.5% since the trade date, from $9.76 to $3.66 (Oct 29, 2026 close).
- Traded
- Jun 12, 2026
- Disclosed
- Jun 13, 2026
- Filing delay
- 1 day
- Price since
- -62.5%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4
More SPRY insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.